Little Known Facts About phenobarbital sodium water solubility.
Little Known Facts About phenobarbital sodium water solubility.
Blog Article
pentobarbital will decrease the level or effect of alprazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
pentobarbital will reduce the extent or effect of zolpidem by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Not known.
pentobarbital will reduce the extent or effect of duvelisib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Stay clear of or Use Alternate Drug. Coadministration with a solid CYP3A inducer decreases duvelisib place under the curve (AUC), which can minimize duvelisib efficacy.
pentobarbital will reduce the level or effect of bazedoxifene/conjugated estrogens by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
pentobarbital will reduce the extent or effect of stiripentol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Keep away from or Use Alternate Drug. If unable to stay away from coadministration of stiripentol with robust CYP3A4 inducers, enhance stiripentol dose.
pentobarbital will reduce the level or effect of copyright topical by influencing hepatic enzyme CYP2B6 metabolism. Minimal/Importance Unidentified.
pentobarbital will lessen the level or effect of etravirine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
pentobarbital decreases levels of elvitegravir/cobicistat/emtricitabine/tenofovir DF by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. May perhaps bring about loss of virologic response and possible resistance.
lasmiditan, pentobarbital. Either increases effects of the other by sedation. Use Caution/Check. Coadministration of lasmiditan and other CNS depressant drugs, like alcohol haven't been evaluated in medical scientific studies. Lasmiditan might cause sedation, get more info together with other cognitive and/or neuropsychiatric adverse reactions.
pentobarbital will reduce the extent or effect of apremilast by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Stay clear of or Use Alternate Drug. Coadministration with robust CYP inducers ends in a substantial lower of systemic publicity of apremilast, which can bring about loss of efficacy
pentobarbital will decrease the level or effect of bortezomib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
Contraindicated (1)pentobarbital will reduce the level or effect of elbasvir/grazoprevir by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will lower the level or effect of alosetron by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Unknown.
pentobarbital will reduce the extent or effect of fruquintinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. If coadministration with reasonable CYP3A4 inducers is unavoidable, proceed to administer fruquintinib at recommended dosage.